Yinduo Zeng

机构：Sun Yat-sen University, Sun Yat-sen Memorial Hospital, Maternal and Child Health Care Hospital of Bao'an, Guangdong Province Women and Children Hospital

发表论文 36 篇 · 总被引 308 次 · h-index 9

代表论文

• Multicenter phase II trial of Camrelizumab combined with Apatinib and Eribulin in heavily pretreated patients with advanced triple-negative breast cancer (2022 · Nature Communications · 被引 104)
• Targeting autophagy plus high-dose CDK4/6 inhibitors in advanced HR+HER2− breast cancer: A phase 1b/2 trial (2024 · Med · 被引 14)
• Assessing real-world safety concerns of Sacituzumab govitecan: a disproportionality analysis using spontaneous reports in the FDA adverse event reporting system (2023 · Frontiers in Oncology · 被引 14)
• First-in-human study of JSKN016, a bispecific anti-TROP2/HER3 antibody drug conjugate (ADC): Antitumor activity in patients (pts) with metastatic triple-negative breast cancer (mTNBC) and safety results. (2025 · Journal of Clinical Oncology · 被引 10)
• Treatment Patterns and Survival Outcomes of Non-Small Cell Lung Cancer Patients Initially Diagnosed With Brain Metastases in Real-World Clinical Practice (2020 · Frontiers in Oncology · 被引 10)
• Identification of DHX36 as a tumour suppressor through modulating the activities of the stress-associated proteins and cyclin-dependent kinases in breast cancer. (2020 · PubMed · 被引 9)